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Abstract 
Background: Female-limited early-onset high myopia, also called Myopia-26 is a rare monogenic disorder character-
ized by severe short sightedness starting in early childhood and progressing to blindness potentially by the middle 
ages. Despite the X-linked locus of the mutated ARR3 gene, the disease paradoxically affects females only, with males 
being asymptomatic carriers. Previously, this disease has only been observed in Asian families and has not gone 
through detailed investigation concerning collateral symptoms or pathogenesis.
Results: We found a large Hungarian family displaying female-limited early-onset high myopia. Whole exome 
sequencing of two individuals identified a novel nonsense mutation (c.214C>T, p.Arg72*) in the ARR3 gene. We car-
ried out basic ophthalmological testing for 18 family members, as well as detailed ophthalmological examination 
(intraocular pressure, axial length, fundus appearance, optical coherence tomography, visual field- testing) as well as 
colour vision- and electrophysiology tests (standard and multifocal electroretinography, pattern electroretinography 
and visual evoked potentials) for eight individuals. Ophthalmological examinations did not reveal any signs of cone 
dystrophy as opposed to animal models. Electrophysiology and colour vision tests similarly did not evidence a general 
cone system alteration, rather a central macular dysfunction affecting both the inner and outer (postreceptoral and 
receptoral) retinal structures in all patients with ARR3 mutation.
Conclusions: This is the first description of a Caucasian family displaying Myopia-26. We present two hypotheses that 
could potentially explain the pathomechanism of this disease.
Keywords: Early onset high myopia, X-linked female-limited high myopia, Intrinsically photosensitive retinal ganglion 
cell, Monogenic disorder, Mendelian inheritance, X-arrestin, ARR3, G-protein coupled receptor
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Background
Myopia or short-sightedness has become a serious 
world health issue recently [1]. This can be attributed to 
its extreme phenotypes on the „upper end of the scale”, 
namely high and pathologic myopia. Cases of high 
myopia with a rapid progression carry the risk of advanc-
ing into pathologic myopia, a condition that is associ-
ated with potentially blinding complications. There is an 
explicit increase in the prevalence of these conditions 
lately, therefore an urgent need for targeted treatments 
is recognized [1, 2]. To devise such treatment options 
however, we need to thoroughly understand the exact 
molecular mechanisms of refractive errors and myopia 
development. Albeit nearly 270 genes associated with 
myopia have been identified so far, the underlying path-
ways through which these genes influence refractive 
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error development remain obscure in most of the cases 
[3].
Inheritance of late onset or common myopia and early 
onset high myopia (eoHM) was evidenced to differ basi-
cally yet earlier [4]. As opposed to common forms, eoHM 
is predominantly inherited in a Mendelian manner with 
one single causative, highly penetrant gene mutation, 
practically with minimal influence of environment or 
behaviour. The specific mode of inheritance of such dis-
eases covers a wide range of forms including autosomal 
dominant, autosomal recessive or X-linked recessive [5]. 
One of the most curious and exceptional modes of trans-
mission is that seen for Myopia-26, displaying X-linked 
dominant inheritance. This rare disease, described ear-
lier only in three Asian families paradoxically affects 
females only, with male hemizygotes being asymptomatic 
(emmetropic) carriers [6]. The ARR3 gene, residing on 
the X-chromosome and encoding the cone-arrestin was 
found to be mutated in all affected patients. Associated 
symptoms were not reported for those cases, neither was 
a potential mechanism of pathogenesis provided.
Today, the general pathomechanism of refractive error 
development is assumed to be based on a retina-to-
sclera signalling cascade guided locally by light stimuli 
in the retina [7]. All retinal cell types seem to participate 
in this retina-specific signal transduction and derail-
ment of retinal cell physiology and light processing are 
the key mechanisms [3]. However, only recent advances 
allowed for deeper insight into the genetic background 
of these processes. There is still much to be discovered 
in this field, especially concerning the specific role of the 
mutated genes in pathogenesis to imply further treatment 
potentials. Promising is the fact that despite their differ-
ent manners of inheritance, there is an overlap between 
eoHM and common myopia in both causative genes and 
pathways of pathogenesis [3].
In our study we investigated a large family of five gen-
erations displaying female-limited eoHM. Whole exome 
sequencing identified an early stop codon within the 
ARR3 gene, verifying the diagnosis of Myopia-26. In 
order to explore the clinical phenotype of this disease 
further, we accomplished thorough ophthalmological 
and electrophysiological testing. Electrophysiology test 
results altogether suggested a central macular retinal 
ganglion cell deficit besides the photoreceptoral distur-
bance, and permitted the formulation of the ganglion-
cell hypothesis to explain the development of myopia, 
in addition to the hypothesis based on the cone-arrestin 
defect.
Results
In the course of our routine ophthalmological work, we 
found multiple interrelated patients displaying eoHM. 
Precisely recording the personal and familial medical 
histories of the patients allowed the compilation of their 
pedigree (Fig.  1). This revealed a family of five genera-
tions comprising numerous affected patients, all of whom 
are females. Assuming a monogenic trait, this pattern 
seemed to be indicative of X-linked heredity where the 
mutant allele is dominant in females, but has no pen-
etrance in males, i.e. it is female limited. We found only 
a single paper describing such transmission of eoHM, 
referred to as Myopia-26. All three reported families 
belonged to the East Asian ethnicity [6].
Fig. 1 The pedigree of the investigated family. Dark shading indicates an eoHM phenotype. Dashed circles mark patients whose blood samples 
were obtained, the two arrows mark the two samples that went through whole exome sequencing
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To identify the causative mutation, DNA prepared 
from the blood samples of patients III/3 and V/8 (a male 
carrier and a symptomatic female, respectively) were sub-
mitted to whole exome sequencing. We identified the 
same variant (NM_004312.2:c.214C>T NP_004303.2:p.
Arg72Ter) in the X chromosome-based ARR3 gene in 
both individuals in hemizygous and heterozygous form, 
respectively. The presence of this candidate pathogenic 
variant was confirmed by conventional PCR amplifica-
tion and Sanger sequencing as well. Segregation of this 
change with the disease was assessed for all available 
family members. We confirmed the presence of this non-
sense variant in heterozygous state in all available symp-
tomatic female members of the family (II/1, II/3, III/8, 
III/13, IV/1, IV/2, IV/6, IV/7, IV/10 and IV/18). We have 
also confirmed the absence of this ARR3 variant from all 
studied asymptomatic females (IV/4, IV/13, IV/14, IV/17 
and V/5). Patient V/6, a healthy male was found to carry 
the wild type allele. To date, this variant has not been 
described in the Human Gene Mutation Database, the 
Exome Aggregation Consortium, the Exome Sequenc-
ing Project, ClinVar or the 1000 Genome Browser. Pre-
diction programs Polyphen2, SIFT, and MutationTaster 
predicted pathogenicity of the nonsense variant. Overall, 
these results confirmed the diagnosis of Myopia-26.
Next, eight of our patients were exposed to a more 
thorough examination. Medical history revealed no other 
notable systemic or ophthalmological disorders relevant 
for this matter. The gender, age, best corrected visual acu-
ities (BCVA), spherical equivalents (SE), intraocular pres-
sures (IOP), axial lengths (available for patients who went 
through scleral reinforcement surgery), fundus appear-
ance (classified according to the META-PM study [8]), 
OCT-, visual field and colour vision test results of these 
patients are shown in Table 1. Examples of our findings 
are shown in Fig. 2 and Additional file 1: Figures S2–S21.
Numerical values extracted from the electrophysiologi-
cal test results are shown in Additional file 3: Tables S1, 
S2 and S3 of the Supplementary text. Examples of stand-
ard full-field electroretinography (ERG) recordings are 
shown in Fig.  3, pattern electroretinography (PERG) in 
Fig. 4, pattern visual evoked potentials (pVEP) in Fig. 5, 
and multifocal electroretinography (mfERG) in Fig. 6. All 
remaining recordings are available in Additional file  2: 
Figures S22–S55.
Some points of note:
1. Fundus, OCT and visual field alterations showed 
no characteristics of cone dystrophy, such as „bull’s 
eye” appearance on the central fundus, outer retinal 
changes with OCT or a central scotoma with visual 
field testing. Rather they were characteristic of high 
myopia: META-PM1-2 fundus appearance (See 
Additional file 3: Supplementary text and Additional 
file 1) and thinner or incipient atrophic sensory ret-
ina on macular OCT scans (Fig. 2).
2. Electrophysiology test results overall indicated a 
macular dysfunction in our patients with ARR3 
mutation apparently affecting both the inner and 
outer retinal structures of the central retina (Figs. 3, 
4, 5, 6), as opposed to a generalized cone dysfunc-
tion expected based on X-arrestin knockout animal 
models [9]. These electrophysiological alterations 
(detailed in the Additional file 3: Supplementary text) 
were detected in all patients with ARR3 mutation 
irrespective of their affected or carrier genetic sta-
tus, and at the same time showed no correlation with 
either the VA, SE or the age of the patients. Accord-
ingly, these alterations are most likely attributable to 
the genetic defect itself, and are not secondary conse-
quences of the high myopic refractive error.
3. Colour vision test results revealed a diffuse colour 
vision discrimination error with no specific axis in 
our patients tested with the Lanthony Desaturated 
D-15-hue Panel test. This is again consistent with the 
central macular deficit suggested by the electrophysi-
ology tests of our patients (see Additional file 3: Sup-
plementary text).
4. Despite the fact that the possibility of an associa-
tion of POAG with high myopia in our patients arose 
(detailed in the Additional file 3: Supplementary text), 
available data do not provide sufficient and inargu-
able evidence to support the diagnosis of POAG at 
present. Long- term follow-up will be necessary to 
reveal any evidence of potential progression of these 
parameters that could also be expected in glaucoma.
Discussion
In this study, we report a family displaying a heritable 
form of eoHM, where the disease is manifested only in 
females. Compilation of the pedigree permitted the iden-
tification of carrier males, and revealed that their female 
offspring are exclusively affected, which suggested an 
X-linked dominant, female-limited inheritance. Whole 
exome sequencing of two individuals indeed revealed a 
nonsense-mutation within the coding region of a gene on 
the X-chromosome, namely ARR3. Sanger sequencing of 
the respective locus in a total of 16 female family mem-
bers unveiled a perfect correlation between the presence 
of the mutant allele and the high myopia phenotype. This 
is the first report of a mutation in ARR3 causing heredi-
tary eoHM, called Myopia-26 in a Caucasian family. 
Three Chinese families have been reported earlier to dis-
play a similar, X-linked dominant, female-limited trans-
mission of eoHM [6]. In those cases the ARR3 was found 
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to carry c.893C>A (p.Ala298Asp), c.298C>T (p.Arg100*) 
and c.239T>C (p.Leu80Pro) mutations, respectively. The 
mutant allele identified in our study (c.214C>T, p.Arg72*) 
is therefore novel. The earlier publication on Myopia-26 
lacked a detailed phenotypic description of the patients, 
and did not attempt to explain the pathomechanism of 
the disease. Our main goals from this point onwards were 
therefore to carry out a thorough ophthalmologic inves-
tigation of the family and use the acquired information, 
along with literature data to build reasonable hypotheses 
on the molecular mechanism of pathogenesis.
ARR3 encodes a 388 amino acid-long visual arrestin 
with multiple names (Arrestin 3, Arrestin 4, Cone-arres-
tin, Retinal cone arrestin-3, X-arrestin), we refer to it as 
Table 1 Clinical findings of the investigated family members
AL axial length, BCVA best corrected visual acuities, CVD color vision defect, E emmetropic (with no refractive error), IOP intraocular pressure, OCT optical coherence 
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X-arrestin. Besides its key role in the phototransduc-
tion process in retinal cones, it is also expressed in pin-
ealocytes of the pineal gland [10]. Arrestins make up an 
important family of proteins, with the primary function 
of desensitizing phosphorylated G-protein coupled 
receptors (GPCRs). Arrestin 1 and X-arrestin bind to 
opsins (hence called visual arrestins), while β-arrestin 1 
and 2 bind to numerous other types of GPCRs. Arres-
tin 1 has very high preference for opsins found in retinal 
rods and cones, whereas X-arrestin has a fairly high bind-
ing capacity to non-opsin binding partners as well, and 
therefore has more diverse synaptic roles [11].
Our knowledge about the function and cell type-
specific expression of X-arrestin is, at this time based 
mostly on experimental data derived from animal mod-
els. X-arrestin is expressed in all cone types of the human 
retina [12], however it displays a weaker expression in 
the S-cones of mice [13]. Arrestin 1, on the other hand 
is detectable in rods and S-cones of baboons, but not in 
LM cones [14]. In the cones of knockout mice, Arrestin-1 
seems to provide a functional replacement for X-arrestin 
[15]. This experimental dataset allows us to formulate two 
reasonable, albeit incomplete hypotheses on the patho-
genesis of myopia in ARR3-mutant patients. We refer 
to these as the cone- and the ganglion cell-hypothesis, 
respectively. The cone-hypothesis assumes that Arres-
tin-1 expression in humans is present in S-cones, but not 
in LM cones, as seen in baboons [14], so an X-arrestin 
defect would lead to limited arrestin function in LM, but 
not in S cones. Since arrestins are responsible for the 
desensitization of opsins, decreased arrestin function in 
LM-cones would mean their increased activity, and the 
“sensitization” to red/green visual stimuli. Such selective 
cone dysfunction could explain the onset of myopia the 
following way. The physical phenomenon of chromatic 
aberration leads to shorter wavelengths forming an image 
in a more anterior, and longer wavelengths forming 
an image in a more posterior plane (Figure S1A). Nor-
mally, the measure of luminance contrast is maximized 
during accommodation, and long-wavelengths form 
an image behind the photoreceptors. In patients with a 
relatively increased sensitivity of L-cones, the posterior 
image will produce a stronger stimulus (Figure S1B). As a 
result, a higher luminance contrast will be attained upon 
increased accommodation and by ocular elongation, two 
hallmarks of myopia pathogenesis [16]. Although accom-
modation excess in itself may not be sufficient to cause 
myopia [17], the phenomenon of image-forming behind 
the retina, called hyperopic defocus has been shown to 
provoke ocular elongation in numerous animal stud-
ies [18, 19]. Briefly, since blue light is claimed to have a 
protective effect against myopia, the relative weaken-
ing of the blue light stimulus upon the loss of X-arrestin 
can explain the eventual development of myopia in these 
patients [20].
The selectively altered function of various cone types, 
however, cannot be tested with standard photopic 3.0 
Fig. 2 a Ultra widefield (Optos® California) fundus image of the 
right eye of affected female patient IV/6 displaying a META-PM2 
stage myopic fundus. The tesselated appearence of the retina along 
with peripapillary and diffuse chorioretinal atrophy is observable. b 
Macular OCT image of the right eye affected female IV/6 displaying 
thinner (incipient atrophic) sensory retina and posterior vitreous 
detachment characteristic of higher degrees of myopia. c Visual field 
of the right eye of affected female IV/6 (nasal loss + superior artefact)
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ERGs. Due to the quite extensively overlapping spec-
tral sensitivities of different photopigments [21], these 
tests reflect the summed activity of all three retinal 
cone types. Photopic 3.0 ERGs indeed, were normal and 
showed no alteration in our patients (Fig. 3). L, M and 
S-cones responses can be isolated electrophysiologi-
cally by recording the light adapted ON/OFF-ERG and 
the S-cone ERG. Similar to the PhNR, these recordings 
are an extension of the full-field ERG [22] which enable 
characterisation of the different cone types, including 
bipolar cell interactions.
Our ganglion cell-hypothesis attributes the develop-
ment of refractive error to the dysfunction of retinal gan-
glion cells (RGC). To better understand this connection, 
one must acknowledge that apart from their primary 
role of transmitting visual information from photorecep-
tors to higher cerebral visual centres, a subset of RGCs 
called intrinsically photosensitive retinal ganglion cells 
(ipRGCs) have an additional role [23]. As their name sug-
gests, they can detect light directly through their photo-
sensitive protein called melanopsin. At the same time, 
they also transduce the signal originating from rod and 
Fig. 3 Normal photopic 3.0 ERGs in affected female IV/7. Despite prominent phenotypic signs of eoHM (SE: − 13.0/ − 9.0D, impaired BCVA, high 
myopic fundus alterations) in IV/7 individual, photopic 3.0 ERGs show no alterations, reflecting an overall normally functioning cone system
(See figure on next page.)
Fig. 4 a Pattern ERG of carrier male III/3 is heavily affected. Despite no phenotypic sign of eoHM and visual impairment, pattern ERG of the carrier 
male patient is similarly subnormal as those of affected female patients. b Heavily affected PERG recordings of affected female IV/7. c Pattern 
ERG of unaffected male V/6. Physiological wave patterns are detected. In all sections, lines 1 and 3 and lines 2 and 4 represent pairs of replicate 
measurements
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cone photoreceptor cells, analogously to classical RGCs 
[24]. Classical and ipRGCs are interconnected horizon-
tally by amacrine cells, which allow them to influence 
the activity of one another [25]. IpRGCs and their light 
sensitive protein, melanopsin are primarily responsible 
for non-image forming visual functions such as circadian 
rhythms or pupil reactions [26–28]. They have recently 
been discovered to play a role in conscious, image-form-
ing visual perception as well [27]. Eye development is 
connected to both image-forming and non-image form-
ing light detection pathways and accordingly refractive 
error may be a consequence of the derailment of either.
There is an increasing body of evidence supporting that 
in the image-forming pathway, light plays a key role in 
emmetropization and refractive error development, and 
besides the intensity, the spectral composition of the light 
stimulus is just as crucial [29, 30]. As opposed to opsins, 
melanopsin is most sensitive to shorter wavelengths 
of the spectrum, i.e. blue light [31]. Besides the anti-
myopic effect of blue light attributed to the myopic defo-
cus it causes on the retina (discussed above) [20], it has 
a further protective effect mediated in part by dopamine 
through pre- and postsynaptic connections of ipRGCs to 
dopaminerg amacrin cells [32]. Dopamine has been long 
acknowledged as a retinal neurotransmitter acting against 
myopia development, and it has also been evidenced that 
blue light stimulates a larger amount of dopamine release 
than other wavelengths do [32]. Accordingly, a disrup-
tion of ipRGC function may result in the alteration of 
the wavelength composition of the perceived light with a 
chromatic aberration shifted towards longer wavelengths 
of the spectrum, along with decreased dopaminergic 
activity. Both issues reduce the protective effect of blue 
light against myopia, potentially leading to the develop-
ment of a progressive refractive error.
The non-image forming visual functions of ipRGCs, 
such as circadian rhythm photoentrainment also play 
an important role in eye development [33]. IpRGCs 
and melanopsin mediate circadian cycles both endog-
enously in the retina (again, through dopamine release) 
and via a systemic route comprising the hypothalamic 
suprachiasmatic nucleus (SCN) and the pineal gland 
through the inhibition of melatonin release in pinealo-
cytes [33]. The circadian clock influences ocular devel-
opment, and disruption of the circadian cycle has been 
found to elongate eye components and yield myopia in 
various myopia models [34]. Therefore, either the pri-
mary defect of ipRGCs or the primary dysfunction of 
pinealocytes (or both) could cause the refractive error 
seen in our patients. Although the prior is difficult to 
explain (discussed below), the latter (pineal malfunc-
tion) is highly probable due to the fact that pinealocytes 
normally express the X-arrestin. Melatonin, the product 
of pinealocytes has been shown to inhibit retinal dopa-
mine synthesis [35], modulate  D2 dopamine-receptor 
expression in the retina of chicks [36] and abolish diurnal 
cycling of dopamine levels in goldfish retina [37]. These 
observations could strongly support the possibility that 
pinealocyte malfunction caused by ARR3 mutations lead 
to altered (probably increased) melatonin levels, which in 
turn cause myopia by impairing the diurnal rhythms of 
the eye.
Currently, the most obviously missing piece of both 
the cone- and the ganglion cell-hypothesis is the cause 
of RGC dysfunction displayed on the PERG recordings. 
Direct linkage to the ARR3 mutation would require 
ARR3 expression in RGCs, which was not detectable in 
mice [15]. However, the promoter of the human ARR3 
and its murine orthologue are markedly different, which 
may result in disparate cell type specific expression as 
well [11]. Another possibility would be the secondary 
malfunction of RGCs, resulting from the altered activity 
of pinealocytes. This could be mediated by the humoral 
control of retinal dopaminerg transmission by the pineal 
gland (described above), or the direct effect of melatonin 
on RGCs via their  MT1 and  MT2 melatonin receptors 
[38]. The details of this control are currently missing, it is 
nevertheless noteworthy that myopes have higher mela-
tonin levels than non-myopes [39]. Finally, altered cone 
function, resulting from reduced X-arrestin levels may 
also negatively influence RGC activity. We nevertheless 
have no reason to believe that the cone- and the ganglion 
cell hypotheses are mutually exclusive, or exclude other 
pathomechanisms.
Another major shortcoming of both the cone- and the 
ganglion cell hypothesis is the lack of explanation for the 
female-limited heredity pattern of myopia. It is especially 
curious that the central macular dysfunction seems to 
be present also in males, without leading to eoHM. We 
assume the presence of a “rescue mechanism” in males, 
or in other words, the lack of a pathological process that 
would lead to an axial length elongation in response to 
Fig. 5 a Pattern VEP recordings of patient III/3 demonstrating increased implicit times and decreased amplitudes of P100 for 15′ (smaller checks) 
stimulation as compared to normal control. b Heavily affected pVEP recordings of affected female IV/7 demonstrating increased peak times and 
decreased amplitudes of P100. c Normal pattern VEP recordings of unaffected male V/6 (Note the change of the voltage scale). In all sections, lines 1 
and 3 display responses to 60′ stimuli and lines 2 and 4 represent responses to 15′ stimuli
(See figure on next page.)
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the central retinal dysfunction. Sex-dependent differ-
ences in retina function have been described in mice, 
and the risk of certain retinal diseases have been shown 
to be sex hormone-dependent in humans [40]. Further 
physiology and molecular biology studies are required 
however to unveil the exact mechanisms responsible for 
Fig. 6 a MfERG recording of carrier male III/3, raw waveform. b MfERG recording and ring analysis of carrier male III/3
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the observed female-limited phenotype. Such research 
may also shed light on why the mutant allele is dominant 
in females. In the course of molecular studies however, 
the limitations of animal models must always be kept 
in mind, despite their great value. For example, an age 
related cone dystrophy was suggested in  Arr4−/− mice 
(Arr4 being the murine orthologue of ARR3) based on 
immune-histochemical findings and the pronounced 
diminishment in photopic flash and flicker ERGs [9]. In 
contrast, no generalized cone dysfunction could be evi-
denced in our patients carrying ARR3 mutation, either 
male or female, according to the electrophysiological and 
ophthalmological phenotypic characterization.
From the clinical point of view, our next investigative 
steps seem well defined: i) cone-specific ERGs (S-cone 
ERGs and ON/OFF ERGs) to isolate individual (L, M, or 
S) cone responses [41] and thus support or exclude our 
selective cone dysfunction hypothesis; ii) post-illumina-
tion pupil response (PIPR) to test melanopsin expressing 
ipRGC function [21] and thus shed light on the extent of 
ipRGC damage. iii) long-term follow-up of the progres-
sion of a potential POAG monitoring IOPs, visual field 
defects, optic nerve head appearances and RNFL OCTs.
Conclusions
Using whole exome sequencing, we identified the patho-
genic mutation of the female-limited early onset high 
myopia observed in our patients to be a premature stop 
codon in the ARR3 gene. This illustrates that contrary to 
its current classification [42], female-limited eoHM, also 




In our genetic study of eoHM we investigated a five-gen-
eration family displaying numerous affected individu-
als in each generation. Blood samples were taken from 
18 family members representing four generations, eight 
of whom went through comprehensive ophthalmologi-
cal and electrophysiological testing. Written informed 
consent was obtained from all individual participants 
included in the study. This study was approved by the 
National Scientific and Research Ethics Committee of 
the Medical Research Council of Hungary (ETT TUKEB, 
registration number 58542-1/2017/EKU). All procedures 
performed in studies involving human participants were 
in accordance with the ethical standards of the National 
Scientific and Research Ethics Committee and with the 
1964 Helsinki declaration and its later amendments or 
comparable ethical standards.
Genetic analyses
Whole exome sequencing (WES) of two family mem-
bers (asymptomatic male III/3, and symptomatic female 
V/8) was performed. Human genomic DNA was pre-
pared from blood samples using the MagCore Genomic 
Whole Blood Kit (RBC Bioscience, New Taipei City, 
Taiwan), according to manufacturer’s instructions. 
Genomic capture was carried out with SureSelect XT 
Human All Exon + UTRs v.5 Exome Kit (Agilent, Santa 
Clara, CA). Massively parallel sequencing was done 
using NextSeq500 Sequencer (Illumina, San Diego, CA) 
in combination with the NextSeq™ 500 High Output Kit 
(1 × 150 bp). Raw sequence data analyses, including base 
calling, de-multiplexing, alignment to the hg19 human 
reference genome (Genome Reference Consortium 
GRCh37), and variant calling, were performed using an 
in-house bioinformatics pipeline. For variant filtration, 
all disease-causing variants reported in HGMD®, Clin-
Var, or in CentoMD® as well as all variants with minor 
allele frequency (MAF) of less than 1% in ExAc database 
were considered. Variants that possibly impair the pro-
tein sequence, i.e., disruption of conserved splice sites, 
missense, nonsense, read-throughs, or small insertions/
deletions, were prioritized. All relevant inheritance pat-
terns were considered. The candidate pathogenic muta-
tion (NM_004312.2:c.214C>T NP_004303.2:p.Arg72Ter) 
was verified by PCR amplification and Sanger sequencing 
for both individuals. Next, the same was done to test for 
the presence of this allele in all remaining DNA samples 
obtained from the family. The predicted pathogenicity of 
the variant identified in this study was tested with Poly-
phen2, SIFT, and MutationTaster.
Clinical investigation
Clinical assessment included comprehensive ophthal-
mological examination and electrophysiological testing. 
Patients’ own and family medical history was registered 
regarding other ophthalmological disorders than eoHM 
as well as any systemic diseases. Best corrected visual 
acuity (BCVA) was recorded (Snellen chart) and refrac-
tive error expressed as spherical equivalent (SE). High 
myopia was specified as SE > − 6.0 dioptres (D) on at least 
one of the eyes. Slit lamp biomicroscopy with applantion 
tonometry and fundus ophthalmoscopy in mydriasis was 
carried out (Topcon SL-D701, Topcon, Tokyo, Japan). 
Digital fundus photography (TRC-501X; Topcon, Tokyo, 
Japan) and in some cases also ultra-wide field (200°) fun-
dus images (Optos® California, Optos, Marlborough, 
MA) were taken. Spectral domain optical coherence 
tomography (macular scan) (Heidelberg Engineering, 
Heidelberg, Germany) was performed where possible. 
Axial length measurements were executed with an opti-
cal biometry system (IOLMaster 700, Carl Zeiss, Jena, 
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Germany). Automated kinetic full-field perimetry was 
carried out with Humphrey Field Analyzer (Carl Zeiss 
Meditec, Jena, Germany).
Electrophysiology
Pattern visual evoked potentials (VEPs), pattern-, stand-
ard full-field- and multifocal electroretinography (ERG) 
were carried out. All electrophysiology tests were per-
formed according to the ISCEV standards [43–46] and 
using the Roland Electrophysiological Test Unit with the 
RETIport 32 software (Roland Consult, Brandenburg a.d. 
Havel, Germany). Please see the Additional file 3: Supple-
mentary text for more details.
Colour vision testing
Colour vision deficiencies were assessed using the Lan-
thony Desaturated D-15-hue Panel tests where possible 
and the Isihara pseudoisochromatic plates (Isihara 24 
plates edition, 2006) in the rest of the cases.
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